Robots take the reins: remote surgery trial launches for cancer patients
NCT ID NCT07382635
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial will test a new robot system designed to help surgeons perform laparoscopic surgery from a remote location. The study includes 98 adults with cancers like colorectal, esophageal, liver, or cervical cancer who need surgery. The main goal is to see how often the surgery can be completed without switching to another method.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Cornerstone Surgical Robot
- What this could lead to
- If successful, this could show that remote robot-assisted surgery is safe and effective for several types of cancer surgeries, potentially expanding access to minimally invasive procedures.
- What could go wrong
- This is an early-stage trial with only 98 participants, so results may not apply widely. Technical failures or complications during remote surgery are possible risks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a plasma beam stop colon polyps from coming back?
- Can AI-Guided home training boost recovery from gastric cancer surgery?
- A stitch in time: could a device make abdominal closure safer?
- Can we predict chemo brain before it happens?
- Your gut bacteria might reveal hidden cancer risk
- Can a new drug combo revive Immunotherapy's power against resistant tumors?